InvestorsHub Logo
icon url

Murph1953

03/13/20 5:46 PM

#19885 RE: B52T38 #19883

B52, then why did China ask for more filters from us and Germany?
icon url

techxen

03/13/20 6:16 PM

#19890 RE: B52T38 #19883

B52T38, those are very good questions and ones that I wish I had an answer to. I referenced the commercialization potential from the CMS press release. CytoSorbents and CMS worked together to earn regulatory clearance just to get the devices imported into China under the "fast-track" review process established by the National Medical Products Administration of the People's Republic of China (NMPA) specifically to address the immediate needs of the coronavirus (COVID-19) pandemic. I cannot believe that Baker McKenzie would have brokered this deal between the companies or CMS agreed to it solely for humanitarian reasons if Cytosorb wasn't in some way potentially superior to the device from Jafron.

From what I have read about Jafron's cartridges (which is very limited) they are still undergoing various trials but apparently can be used in and outside of China. In fact Jafron struck up a deal with Saudi Arabia for not only their HA330 cartridge but along with their DX10 blood purification machine. http://www.jafron.com/index.php?m=content&c=index&a=show&catid=96&id=991

Jafron has so many cartridges each one with a different purpose and I believe HA380 is the latest 'new and improved' version. If you look at these products on the company's web site this might be an indication why Cytosorb is superior in that it can do what 7 of their cartridges do: http://www.jafron.com/index.php?m=content&c=index&a=lists&catid=103 (again I have not done an in-depth review and comparison of these with Cytosorb).

Here is Jafron's main Coronavirus web page featuring HA380/HA330, which is a very interesting read.

To cut Dr. Ronco some slack it does appear they have put his picture in several places on their web site as their 'advisor' and even too liberties of listing Professor Jean-Louis Vincent as 'being invited as the research consultants for the new observational study I posted about earlier.

Bottom line, is after reviewing their products and web site I have to believe that Cytosorb is indeed a superior product and maybe out of desperation this is why China Medical Systems saw this opportunity.

However the company may be fighting an uphill battle in China - Jafron's Chairman of the Board Dong Fan lists as first of his credentials is "Member of the Communist Party of China".